Pain Control In First Trimester Medical Abortion: A Randomized Trial
- Registration Number
- NCT01457521
- Lead Sponsor
- Gynuity Health Projects
- Brief Summary
This trial will compare two oral analgesic regimens in women undergoing first trimester medical abortion with mifepristone and misoprostol. The primary study outcome is pain.
- Detailed Description
This trial will compare two oral analgesic regimens in women undergoing first trimester medical abortion with mifepristone and misoprostol. The primary study outcome is pain. Secondary objectives include comparing the regimens for the total amount of ibuprofen taken, use of other analgesics, vaginal bleeding, adverse events, successful completion of abortion, overall satisfaction with the abortion procedure.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 250
- Pregnant women with a gestational age of 63 days or less
- Desire a medical abortion with mifepristone and misoprostol
- Have contraindications to ibuprofen
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Therapeutic Ibuprofen Ibuprofen Prophylactic Ibuprofen Ibuprofen
- Primary Outcome Measures
Name Time Method 11-point Visual Analog Scale for Pain 1-2 weeks Participant pain was assessed using an 11-point Visual Analog Scale for Pain. Scores ranged from 0 (no pain) to 10 (worst pain possible)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Family Planning Associates Medical Group
🇺🇸Chicago, Illinois, United States
Planned Parenthood of New York City, Inc.
🇺🇸New York, New York, United States